%0 Journal Article
%T Flexible bronchoscopy may decrease respiratory muscle strength: premedicational midazolam in focus
%A Tulek Baykal
%A Kanat Fikret
%A Tol Sule
%A Suerdem Mecit
%J Multidisciplinary Respiratory Medicine
%D 2012
%I BioMed Central
%R 10.1186/2049-6958-7-31
%X Background Flexible bronchoscopy (FB) is a procedure accepted to be safe in general, with low complication rates reported. On the other hand, it is known that patients with pre-existing respiratory failure have developed hypoventilation following FB. In this study the effects of FB on respiratory muscle strength were investigated by measuring maximum respiratory pressures. Methods One hundred and forty patients, aged between 25 and 90 years, who had undergone diagnostic bronchoscopy between February 2012 and May 2012, were recruited to the study. Pre- and post-procedure maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were measured. A correlation between the MIP and MEP changes and patient characteristics and FB variables were investigated. Results Significant decreases in both MIP and MEP values were observed following FB (p < 0.001 for both). Decreases were attributed to the midazolam used for sedation. Significant decreases in respiratory muscle strengths were observed especially in the high-dose midazolam group, compared to both low-dose and non-midazolam groups. Conclusions It was determined that respiratory muscle weakness may arise post-procedure in patients who have undergone FB, and this is constitutively related to midazolam premedication. Respiratory muscle weakness might play a role in potential hypoventilation in critical patients who undergo FB.
%K Bronchoscopy
%K Midazolam
%K Respiratory muscle strength
%U http://www.mrmjournal.com/content/7/1/31